Clinical Pharmacogenetic Testing and the Posttest Counseling Conundrum
- 27 June 2020
- journal article
- editorial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 108 (5), 924-928
- https://doi.org/10.1002/cpt.1913
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant PharmacotherapyClinical Pharmacology & Therapeutics, 2019
- Pharmacogenomics courses in pharmacy school curriculaPharmacogenomics, 2019
- Reactive, Point-of-Care, Preemptive, and Direct-to-Consumer Pharmacogenomics TestingPublished by Elsevier BV ,2019
- Genetic counselling, patient education, and informed decision-making in the genomic eraSeminars in Fetal and Neonatal Medicine, 2018
- Collaborative Counseling Considerations for Pharmacogenomic TestsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- Pharmacogenomics in the clinicNature, 2015
- Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacistsPharmacogenomics, 2013
- Primary care physicians' knowledge of and experience with pharmacogenetic testingClinical Genetics, 2012
- Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testingClinical Genetics, 2012
- Delivering a Pharmacogenetic Service: Is There a Role for Genetic Counselors?Journal of Genetic Counseling, 2011